Xvivo Perfusion AB (XVIVO) - Total Assets

Latest as of December 2025: Skr2.37 Billion SEK ≈ $255.49 Million USD

Based on the latest financial reports, Xvivo Perfusion AB (XVIVO) holds total assets worth Skr2.37 Billion SEK (≈ $255.49 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Xvivo Perfusion AB shareholders equity for net asset value and shareholders' equity analysis.

Xvivo Perfusion AB - Total Assets Trend (2011–2025)

This chart illustrates how Xvivo Perfusion AB's total assets have evolved over time, based on quarterly financial data.

Xvivo Perfusion AB - Asset Composition Analysis

Current Asset Composition (December 2025)

Xvivo Perfusion AB's total assets of Skr2.37 Billion consist of 29.0% current assets and 71.0% non-current assets.

Asset Category	Amount (SEK)	% of Total Assets
Cash & Equivalents	Skr292.09 Million	12.3%
Accounts Receivable	Skr147.66 Million	6.2%
Inventory	Skr248.46 Million	10.5%
Property, Plant & Equipment	Skr213.88 Million	9.0%
Intangible Assets	Skr840.29 Million	35.4%
Goodwill	Skr610.06 Million	25.7%

Asset Composition Trend (2011–2025)

This chart illustrates how Xvivo Perfusion AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Xvivo Perfusion AB.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Xvivo Perfusion AB's current assets represent 29.0% of total assets in 2025, an increase from 0.0% in 2011.
Cash Position: Cash and equivalents constituted 12.3% of total assets in 2025, up from 1.7% in 2011.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 60.0% of total assets, an increase from 1.0% in 2011.
Asset Diversification: The largest asset category is intangible assets at 35.4% of total assets.

Xvivo Perfusion AB Competitors by Total Assets

Key competitors of Xvivo Perfusion AB based on total assets are shown below.

Company	Country	Total Assets
Demant A/S CO:DEMANT	Denmark	Dkr39.07 Billion
Sino Medical Sciences Technology In SHG:688108	China	CN¥1.34 Billion
Polynovo Ltd AU:PNV	Australia	AU$127.41 Million
Beijing Succeeder Technology Inc SHG:688338	China	CN¥1.75 Billion
Tellgen Corp SHE:300642	China	CN¥2.00 Billion
Respiri Ltd AU:RSH	Australia	AU$7.08 Million
Diagnostic Medical Systems SA PA:ALDMS	France	€57.17 Million
Atomo Diagnostics Ltd AU:AT1	Australia	AU$9.48 Million

Xvivo Perfusion AB - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	5.77	4.58	6.15
Quick Ratio	3.68	3.30	5.29
Cash Ratio	2.45	2.34	0.00
Working Capital	Skr568.83 Million	Skr635.57 Million	Skr389.82 Million

Xvivo Perfusion AB - Advanced Valuation Insights

This section examines the relationship between Xvivo Perfusion AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.75
Latest Market Cap to Assets Ratio	0.39
Asset Growth Rate (YoY)	-1.2%
Total Assets	Skr2.37 Billion
Market Capitalization	$930.17 Million USD

Valuation Analysis

Below Book Valuation: The market values Xvivo Perfusion AB's assets below their book value (0.39x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Xvivo Perfusion AB's assets decreased by 1.2% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Xvivo Perfusion AB (2011–2025)

The table below shows the annual total assets of Xvivo Perfusion AB from 2011 to 2025.

Year	Total Assets	Change
2025-12-31	Skr2.37 Billion ≈ $255.49 Million	-1.19%
2024-12-31	Skr2.40 Billion ≈ $258.57 Million	+9.43%
2023-12-31	Skr2.20 Billion ≈ $236.28 Million	+26.69%
2022-12-31	Skr1.73 Billion ≈ $186.51 Million	+12.35%
2021-12-31	Skr1.54 Billion ≈ $166.01 Million	+34.10%
2020-12-31	Skr1.15 Billion ≈ $123.79 Million	+81.30%
2019-12-31	Skr634.49 Million ≈ $68.28 Million	+8.16%
2018-12-31	Skr586.61 Million ≈ $63.13 Million	+8.93%
2017-12-31	Skr538.54 Million ≈ $57.96 Million	+54.18%
2016-12-31	Skr349.30 Million ≈ $37.59 Million	+71.07%
2015-12-31	Skr204.18 Million ≈ $21.97 Million	+1.23%
2014-12-31	Skr201.70 Million ≈ $21.71 Million	+58.12%
2013-12-31	Skr127.56 Million ≈ $13.73 Million	+11.39%
2012-12-31	Skr114.52 Million ≈ $12.32 Million	-18.71%
2011-12-31	Skr140.88 Million ≈ $15.16 Million	--

About Xvivo Perfusion AB

ST:XVIVO Sweden Medical Devices

Market Cap

$930.17 Million

Skr8.64 Billion SEK

Market Cap Rank

#9416 Global

#141 in Sweden

Share Price

Skr274.40

Change (1 day)

-0.72%

52-Week Range

Skr160.80 - Skr333.00

All Time High

Skr539.00